Counterpoint Mutual Funds LLC Purchases Shares of 47,639 Amprius Technologies, Inc. $AMPX

Counterpoint Mutual Funds LLC acquired a new stake in Amprius Technologies, Inc. (NYSE:AMPX) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 47,639 shares of the company’s stock, valued at approximately $501,000.

Several other hedge funds have also added to or reduced their stakes in AMPX. Jones Financial Companies Lllp boosted its stake in Amprius Technologies by 353.2% in the 3rd quarter. Jones Financial Companies Lllp now owns 4,532 shares of the company’s stock valued at $50,000 after purchasing an additional 3,532 shares during the period. Geneos Wealth Management Inc. acquired a new stake in shares of Amprius Technologies during the third quarter worth $74,000. Ameritas Investment Partners Inc. boosted its position in shares of Amprius Technologies by 2,043.2% in the second quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock valued at $40,000 after acquiring an additional 9,072 shares during the period. Legal & General Group Plc boosted its position in shares of Amprius Technologies by 1,385.4% in the second quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock valued at $44,000 after acquiring an additional 9,684 shares during the period. Finally, XTX Topco Ltd acquired a new position in shares of Amprius Technologies in the second quarter valued at about $44,000. 5.04% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Amprius Technologies

In other Amprius Technologies news, Director Kang Sun sold 61,251 shares of the firm’s stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $10.16, for a total value of $622,310.16. Following the sale, the director owned 1,342,400 shares of the company’s stock, valued at approximately $13,638,784. This trade represents a 4.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CTO Constantin Ionel Stefan sold 25,366 shares of Amprius Technologies stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $10.16, for a total value of $257,718.56. Following the completion of the transaction, the chief technology officer owned 723,330 shares in the company, valued at approximately $7,349,032.80. The trade was a 3.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 2,392,269 shares of company stock valued at $26,384,359 over the last 90 days. Corporate insiders own 12.80% of the company’s stock.

Amprius Technologies Trading Up 6.1%

Shares of Amprius Technologies stock opened at $10.82 on Wednesday. The company has a market cap of $1.41 billion, a PE ratio of -41.61 and a beta of 2.98. The company has a 50 day moving average of $10.27 and a 200-day moving average of $10.45. Amprius Technologies, Inc. has a 1-year low of $1.70 and a 1-year high of $16.03.

Wall Street Analyst Weigh In

Several analysts have weighed in on AMPX shares. Needham & Company LLC started coverage on shares of Amprius Technologies in a research note on Thursday, January 29th. They issued a “buy” rating and a $20.00 price objective for the company. Cantor Fitzgerald raised their target price on shares of Amprius Technologies from $12.00 to $16.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Craig Hallum began coverage on Amprius Technologies in a research report on Monday. They set a “buy” rating and a $17.00 price target on the stock. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $17.00 price objective on shares of Amprius Technologies in a report on Tuesday, December 23rd. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $16.63.

Amprius Technologies Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.